Citalopram
Product Images NDC 52959-773

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 52959-773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure 1 (Str 1)

FDA Label Image

Package Label.principal Disply Panel (20 MG(100's Bottle))

Package Label.principal Disply Panel (20 MG(100's Bottle))
This is a description of a Citalopram Hydrochloride 20mg tablet manufactured by Aurobindo. It comes in a lot number CIHOOQV and is set to expire on 08/11. It is meant to be taken as directed by a doctor. The caution information is not clearly legible due to errors in . Pill ID shows it being a light pink biconvex capsule and it can be compared to Celexa. The text contains multiple lot numbers associated with the product including ClHoDQY, CIHO0QY, and 52050-773-30. It also mentions a manufacturer with NDC code 13107-006-05 and location in Dayton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.